Q4 2021 Holdings
Filed 2022-02-14 | 9 holdings | $945.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics, Inc. | COM | 48576A100 | $381.6K | 2,912,872 | 40.4% |
| Eqrx, Inc. | COM | 26886C107 | $247.8K | 36,335,375 | 26.2% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $172.2K | 11,055,554 | 18.2% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $92.5K | 2,508,809 | 9.8% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $43.9K | 3,798,926 | 4.6% |
| Rubius Therapeutics, Inc. | COM | 78116T103 | $3.4K | 349,908 | 0.4% |
| Natera, Inc.(NTRA) | COM | 632307104 | $3.0K | 32,098 | 0.3% |
| Zymergen Inc. | COM | 98985X100 | $797 | 119,205 | 0.1% |
| Pulmatrix, Inc. | COM | 74584P202 | $19 | 43,639 | 0.0% |